Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
This paper changed my life: Abigail Person on birdsong, feed-forward circuits and convergent computations
By isolating specific neuron types involved in zebra finch birdsong, this 2002 Nature paper from Michael Fee and colleagues revealed elegant neural mechanisms controlling the timing of natural learned behavior.
This paper changed my life: Abigail Person on birdsong, feed-forward circuits and convergent computations
By isolating specific neuron types involved in zebra finch birdsong, this 2002 Nature paper from Michael Fee and colleagues revealed elegant neural mechanisms controlling the timing of natural learned behavior.
By
Abigail Person
12 August 2025 | 6 min listen
Prosocial effects of oxytocin are state dependent; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 August.
Prosocial effects of oxytocin are state dependent; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 August.
By
Jill Adams
12 August 2025 | 2 min read
The challenge of defining a neural population
Our current approach is largely arbitrary. We need new methods for grouping cells, ideally by their dynamics.
The challenge of defining a neural population
Our current approach is largely arbitrary. We need new methods for grouping cells, ideally by their dynamics.
By
Mark Humphries
11 August 2025 | 9 min listen